Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE (Cyclosporine Ophthalmic Solution) 0.1% from Novaliq

18.07.2023 - Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, and Novaliq GmbH, a German biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced an agreement under which Harrow will acquire the ... Seite 1

Related Keywords

Canada ,Washington ,United States ,Seattle ,Canadian ,Lauram Periman ,Markl Baum , ,Periman Eye Institute ,Clinical Research ,Eye Services ,Chief Executive Officer ,Dry Eye Services ,Harrow Health ,